Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Griscelli syndrome type 2 (GS2) is a rare, inherited condition that affects the skin, hair, and immune system. People with GS2 have unusually light skin and silver-colored hair. They are also prone to recurrent infections and develop an immune condition called hemophagocytic lymphohistiocytosis (HLH). HLH can damage organs and tissues throughout the body, causing life-threatening complications. GS2 is caused by changes (mutations) in the RAB27A gene and is inherited in an autosomal recessive manner. The only current treatment that can extend survival is stem cell transplantation (a bone marrow transplant). Untreated, most children with GS2 do not survive past early childhood.
Features include always present findings: Melanin pigment aggregation in hair shafts, Silver-gray hair, and Hepatosplenomegaly; and very common findings: Hemophagocytosis, Enlarged spleen (splenomegaly), Low blood cell counts (all types) (pancytopenia), and Premature graying of hair and others. 28 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 5 | Recurrent bacterial infections, Enlarged spleen (splenomegaly), Decreased total neutrophil count |
RAB27A function has not been fully characterized.
Griscelli syndrome type 2 is caused by mutations in the RAB27A gene on chromosome 15.
Genetic testing for RAB27A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Griscelli syndrome type 2 has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 8 very common features, 4 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Griscelli syndrome type 2.
145 publications have been identified in PubMed for Griscelli syndrome type 2. Research spans Review / Meta-Analysis (28%), Basic Science / Preclinical (22%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 41 | 28% |
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 1:59 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Griscelli syndrome type 2
Digestive system | 5 | Hepatosplenomegaly, Jaundice, Enlarged spleen (splenomegaly) |
Brain and nerves | 2 | Seizure, Spasticity |
Metabolism | 2 | Fever, High blood fat levels (hyperlipidemia) |
Skin | 1 | Hypopigmentation of the skin |
Lungs and breathing | 1 | Pulmonary infiltrates |
32 |
22% |
Patient case studies | 24 | 17% |
Disease patterns and progression | 22 | 15% |
Clinical study results | 13 | 9% |
Testing and diagnosis research | 7 | 5% |
New treatment approaches | 6 | 4% |
Aldahi WA (2026). [PMID: 41678007](https://pubmed.ncbi.nlm.nih.gov/41678007/). *Diabetes therapy : research, treatment and education of diabetes and related disorders*. [Case Report / Case Series]
Leoni C (2026). [PMID: 42026675](https://pubmed.ncbi.nlm.nih.gov/42026675/). *Orphanet J Rare Dis*. [Case Report / Case Series]
Gao F (2026). [PMID: 41655128](https://pubmed.ncbi.nlm.nih.gov/41655128/). *Autophagy*. [Basic Science / Preclinical]
Mammadova N (2026). [PMID: 40518752](https://pubmed.ncbi.nlm.nih.gov/40518752/). *Clinical genetics*. [Review / Meta-Analysis]
White RT (2026). [PMID: 41947645](https://pubmed.ncbi.nlm.nih.gov/41947645/). *Pharmacotherapy*. [Review / Meta-Analysis]
Zhang Y (2026). [PMID: 41833577](https://pubmed.ncbi.nlm.nih.gov/41833577/). *EBioMedicine*. [Epidemiology / Natural History]
Ribeiro MVG (2026). [PMID: 42107303](https://pubmed.ncbi.nlm.nih.gov/42107303/). *Nutr Res*. [Basic Science / Preclinical]
Coca A (2026). [PMID: 41875318](https://pubmed.ncbi.nlm.nih.gov/41875318/). *J Hypertens*. [Review / Meta-Analysis]
Kocak Eker H (2026). [PMID: 41854160](https://pubmed.ncbi.nlm.nih.gov/41854160/). *Clin Genet*. [Basic Science / Preclinical]
Curcio A (2026). [PMID: 41652617](https://pubmed.ncbi.nlm.nih.gov/41652617/). *Journal of translational medicine*. [Review / Meta-Analysis]